6
VARGIU ET AL.
1H‐NMR (250 MHz, CDCl3) δ: 9.39 (d, J = 7.9 Hz, 0.5H,
CHO anti), 9.26 (d, J = 7.8 Hz, 0.5H, CHO syn), 7.38 to
7.14 (m, 3H, Ar―H), 6.61 to 6.40 (m, 2H, H4, H3′), 6.17
(dd, J = 9.6, 6.0 Hz, 0.5H, H3), 6.06 to 5.90 (m, 1H, H3,
H2′), 5.85 (dd, J = 15.6, 8.0 Hz, 0.5H, H2′), 5.12 to 4.97
(m, 1H, H2), 3.82 (s, 1.5H, NCOOCH3), 3.75 (s, 1.5H,
NCOOCH3), 2.53 to 2.29 (m, 1H, H4′), 1.73 to 1.06 (m,
4H, H5′, H6′), 0.85 (t, J = 7.28 Hz, 1.5H, H7′), 0.84 (t,
J = 7.42 Hz, 1.5H, H7′).13C‐NMR (63 MHz, CDCl3) δ:
193.6, 193.3, 158.0, 156.9, 135.2, 134.8, 134.0, 133.4,
130.8, 129.4, 129.2, 129.0, 129.0, 128.2, 126.7, 126.4,
125.5, 125.4, 117.6, 55.2, 54.8, 53.6, 53.5, 47.8, 47.8, 32.2,
32.1, 29.8, 29.5, 22.8, 20.7, 20.2, 14.1, 14.0. HRMS (ESI)
m/z [M + Na+] Calcd for C18H20BrNO3Na 400.0519,
found 400.0517. The ee's were determined with Daicel
Chiralcel AD‐H column (heptane–i‐PrOH, 96:4) flow rate
1.0 mL/min; 220 nm; diastereomer 1: 42% ee tr (minor):
10.94 minutes, tr (major): 10.26 minutes; diastereomer 2:
33% ee, tr (minor): 10.83 minutes, tr (major):
12.00 minutes.
2.13 | Methyl (E)(3R*)‐2‐((4R)1‐oxohept‐2‐
en‐4‐yl)4,7‐dichloroquinoline‐1(2H)‐
carboxylate (2i‐syn,anti)
According to the general procedure, methyl‐4,7‐dichloro‐
2‐ethoxyquinoline‐1(2H)‐carboxylate
(45.1
mg,
0.15 mmol), trans‐2‐heptenal (52.03 mg, 0.45 mmol, 97%),
L3b (18.5 mg, 0.03 mmol, 97%), In(OTf)3 (16.9 mg,
0.03 mmol), H2O (1.1 μL, 0.06 mmol), and toluene
(0.6 mL) reacted for 28 hours. Subsequent semipreparative
TLC (hexanes/AcOEt 8:2, three runs, Rf = 0.4) afforded
17.4 mg (32% yield) of the title compounds as a colourless
1
oil. H‐NMR (250 MHz, CDCl3) δ: 9.38 (d, J = 7.8 Hz,
0.40H, CHO anti), 9.26 (d, J = 7.7 Hz, 0.60H, CHO syn),
7.57 to 7.37 (m, 2H), 7.21 to 7.11 (m, 1H), 6.47 (dd,
J = 15.6, 6.5 Hz, 1H, H3′), 6.24 (d, J = 6.7 Hz, 0.40H, H3
anti), 6.11 (d, J = 6.6 Hz, 0.60H, H3 syn), 5.98 (dd,
J = 14.3, 6.4 Hz, 0.60H, H2′ syn), 5.89 (dd, J = 15.38,
8.4 Hz, 0.40 H, H2′ anti), 5.17 to 5.08 (m, 1H, H2), 3.85 (s,
1.80H, NCOOCH3 syn), 3.79 (s, 1.20H, NCOOCH3 anti),
2.53 to 2.28 (m, 1H, H4′), 1.27 to 1.24 (bs, 4H, H5′, H6′),
0.89 to 0.83 (m, 3H, H7′).13C‐NMR (63 MHz, CDCl3) δ:
193.4, 193.0, 157.1, 155.9, 154.5, 135.4, 135.1, 134.9, 125.8,
125.7, 125.3, 125.2, 125.0, 124.8, 124.5, 124.1, 56.3, 56.0,
53.9, 47.8, 47.6, 45.7, 32.2, 32.1, 29.8, 22.8, 20.6, 20.1, 14.1,
2.12 | Ethyl (E)(3R*)‐2‐((4R)1‐oxohept‐2‐
en‐4‐yl)6‐methoxyquinoline‐1(2H)‐
carboxylate (2h‐syn,anti)
14.0. HRMS (ESI) m/z [M
+
Na+] Calcd for
C20H25Cl2NO3Na 390.0634, found 390.0629. The ee was
determined with Daicel Chiralcel AD‐H column (hep-
tane–i‐PrOH, 92:8) flow rate 0.5 mL/min; 220 nm; one dia-
stereoisomer: tr (minor): 8.7 minutes, tr (major):
9.0 minutes.
According to the general procedure, ethyl‐2,6‐
dimethoxyquinoline‐1(2H)‐carboxylate
(39.5
mg,
0.15 mmol), trans‐2‐heptenal (52.03 mg, 0.45 mmol, 97%),
L3b (18.5 mg, 0.03 mmol, 97%), In(OTf)3 (16.9 mg,
0.03 mmol), H2O (1.1 μL, 0.06 mmol), and toluene
(0.6 mL) reacted for 4 hours. Subsequent semipreparative
TLC (hexanes/AcOEt 7:3, one run, Rf = 0.28) afforded
25.5 mg (50% yield) of the title compounds as a colourless
2.14 | Methyl (E)(3S)‐2‐((4R)1‐oxohept‐2‐
en‐4‐yl)4‐bromoquinoline‐1(2H)‐
carboxylate (2j‐syn)
1
oil. H‐NMR (250 MHz, CDCl3) δ: 9.34 (d, J = 7.9 Hz,
0.6H, CHO anti), 9.23 (d, J = 7.9 Hz, 0.4H, CHO syn),
8.04 to 7.74 (m, 3H, Ar―H), 6.52 (d, J = 9.5 Hz, 1H, H4),
6.65 to 6.42 (m, 2H, olefinic protons), 6.02 to 5.79 (m, 1H,
olefinic proton), 5.12 to 4.93 (m, 1H, H2); 4.35 to 4.06 (m,
2H, NCOOCH2CH3), 3.79 (s, 3H, Ar―OCH3); 2.54 to 2.27
(m, 1H, H4′), 1.68 to 1.04 (m, 4H, H5′, H6′), 0.85 (t,
J = 7.38, 0.6H, H7′ anti), 0.84 (t, J = 7.38, 0.4H, H7′
syn).13C‐NMR (63 MHz, CDCl3) δ: 193.9, 193.6, 162.9,
158.6, 157.8, 156.5, 156.5, 134.8, 134.5, 129.3, 129.1, 128.6,
128.4, 128.2, 126.6, 126.5, 126.0, 113.6, 113.5, 111.0, 111.0,
62.4, 62.3, 55.6, 55.0, 54.7, 47.7, 44.4, 32.4, 32.2, 29.8, 27.5,
20.7, 20.2, 14.6, 14.1, 14.0. HRMS (ESI) m/z [M + Na+]
Calcd for C20H25NO4Na 366.1676, found 366.1780. The
ee's were determined with Daicel Chiralcel AD‐H column
(heptane–i‐PrOH, 96:4) flow rate 1.0 mL/min; 220 nm;
syn 11% ee, tr (minor): 10.00 minutes, tr (major):
12.24 minutes; anti: 40% ee, tr (minor): 13.57 minutes, tr
(major): 15.72 minutes.
According to the general procedure, methyl‐4‐bromo‐2‐
methoxyquinoline‐1(2H)‐carboxylate
(74.5
mg,
0.25 mmol), trans‐2‐heptenal (115.7 mg, 0.75 mmol,
95%), L3b (29.9 mg, 0.05 mmol, 97%), In(OTf)3
(28.1 mg, 0.05 mmol), H2O (1.8 μL, 0.10 mmol), and tol-
uene (1.0 mL) reacted for
2 hours. Subsequent
semipreparative TLC (hexanes/AcOEt 8:2, three runs,
Rf = 0.46) afforded 20 mg (21% yield) of the title com-
1
pound as a colourless oil. H‐NMR (250 MHz, CDCl3)
δ: 9.18 (d, J = 7.8 Hz, 1H, CHO); 7.55 (d, J = 7.7 Hz,
1H, Ar―H); 7.46 to 7.11 (m, 3H, Ar―H); 6.47 to 6.34
(m, 2H, H3′ + H3); 5.94 (dd, J = 15.5, 7.9 Hz, 1H, H2);
5.08 (t, J = 6.9 Hz, 1H, H2); 3.82 (s, 3H, NCOOCH3);
2.57 to 2.39 (m, 1H, H4′); 1.63 to 1.25 (m, 4H,
H5′ + H6′); 0.84 (t, J = 6.69 Hz, 3H, H7′).13C‐NMR
(63 MHz, CDCl3) δ: 193.1, 156.2, 135.0, 130.6, 129.4,